HEXIM1 and breast carcinoma: Interestingly, HEXIM1 expression did not correlate with the malignant features of the breast cancer cell lines; it was moderately reduced in three invasive cancer lines and ZR75B non-invasive cancer line, but remained high in the metastatic MDA-MB-231 cells (Figure 1D).